| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Nov 6, 2025 | AN2 Therapeutics, Inc. | Chief Strategy Officer | Sell | 47.5 | -765 | -1.15% | ✗ | $872.1 |
| Jan 3, 2025 | Jan 7, 2025 | AN2 Therapeutics, Inc. | Chief Strategy Officer | Sell | 47.5 | -2,029 | -5.74% | ✗ | $2.7K |